On June 20, 2024, Three Leaves Biopharmaceutical Co., Ltd. held its annual shareholders' meeting and voted on multiple resolutions. All resolutions were overwhelmingly passed, including the adoption of the audited comprehensive financial statements and board of directors and auditor reports for the fiscal year ending December 31, 2023, the re-election of three directors including Dr. Liang Peng, authorization of the board of directors to determine director compensation, the reappointment of Ernst & Young as the auditor, and the granting of general authorization for directors to issue and repurchase shares. In addition, the revised outline and details of the company's articles of association, as proposed in the special resolution, were also passed. On the day of the shareholders' meeting, the total number of issued shares was 1,297,047,429, and the total number of voting shares was 1,237,381,403. Except for four directors who were unable to attend due to official business, all other directors participated in the meeting in person or via electric appliances. The voting at the meeting was supervised by Hong Kong Central Securities Depository Limited.

On June 20, 2024, Three Leaves Biopharmaceutical Co., Ltd. held its annual shareholders' meeting and voted on multiple resolutions. All resolutions were overwhelmingly passed, including the adoption of the audited comprehensive financial statements and board of directors and auditor reports for the fiscal year ending December 31, 2023, the re-election of three directors including Dr. Liang Peng, authorization of the board of directors to determine director compensation, the reappointment of Ernst & Young as the auditor, and the granting of general authorization for directors to issue and repurchase shares. In addition, the revised outline and details of the company's articles of association, as proposed in the special resolution, were also passed. On the day of the shareholders' meeting, the total number of issued shares was 1,297,047,429, and the total number of voting shares was 1,237,381,403. Except for four directors who were unable to attend due to official business, all other directors participated in the meeting in person or via electric appliances. The voting at the meeting was supervised by Hong Kong Central Securities Depository Limited.